Clorazepate Dipotassium
29 NDCs across 5 manufacturers|29 Generic,0 Brand
Clorazepate Dipotassium is used to treat alcohol withdrawal delirium, anxiety disorders and partial epilepsies, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jun 23, 1987. FDA's Orange Book lists 13 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $11 million on Clorazepate Dipotassium across 131,000 claims for 24,000 beneficiaries.
Clorazepate Dipotassium is available as 29 NDCs from 5 manufacturers (29 generic, 0 brand), with NADAC prices from $0.52 to $0.84 per EA — a 60% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
29
29G / 0B
Manufacturers
5
competing in market
Price Spread
$0.52 – $0.84
per EA
7d Activity
avg -7.7% WoW · of 29 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
ANI Pharmaceuticals, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Benzodiazepine class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing CLORAZEPATE DIPOTASSIUM
Frequently Asked Questions
What is Clorazepate Dipotassium used to treat?
Clorazepate Dipotassium is used to treat alcohol withdrawal delirium, anxiety disorders and partial epilepsies, per the National Library of Medicine's MED-RT classification.
When did Clorazepate Dipotassium become available as a generic?
FDA approved the first generic Clorazepate Dipotassium (ANDA) on Jun 23, 1987. The Orange Book currently lists 13 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Clorazepate Dipotassium?
In 2024, Medicare Part D spent $11 million on Clorazepate Dipotassium across 131,000 claims for 24,000 beneficiaries.
How many Clorazepate Dipotassium products are on the market?
The Clorazepate Dipotassium drug market contains 29 NDCs from 5 manufacturers — 29 generic and 0 brand products.
What is the price range for Clorazepate Dipotassium?
NADAC reference prices for Clorazepate Dipotassium range from $0.5241 to $0.8386 per EA — a 60% difference between cheapest and most expensive.
Which manufacturers make Clorazepate Dipotassium?
5 manufacturers list Clorazepate Dipotassium in NADAC. Ranked by number of NDCs, the largest are ANI Pharmaceuticals, Inc. (9), Aurolife Pharma LLC (9), Taro Pharmaceuticals U.S.A. Inc. (5), Apotex Corp. (3), NorthStar Rx LLC (3).
How has the price of Clorazepate Dipotassium changed recently?
Over the past 7 days, 0 Clorazepate Dipotassium NDCs rose and 29 fell, with a market-wide average change of -7.7%.